Publications

Found 7 results

Filters: Author is Kaunzner, Ulrike W [Clear All Filters]

Journal Article

Kaunzner UW, Kumar G, Askin G, Gauthier SA, Nealon NN, Vartanian T, Perumal JS. 2016. A study of patients with aggressive multiple sclerosis at disease onset.. Neuropsychiatr Dis Treat. 12:1907-12.

Kaunzner UW, Kang Y, Monohan E, Kothari PJ, Nealon N, Perumal J, Vartanian T, Kuceyeski A, Vallabhajosula S, P Mozley D et al.. 2017. Reduction of PK11195 uptake observed in multiple sclerosis lesions after natalizumab initiation.. Mult Scler Relat Disord. 15:27-33.

Kocsik AS, Klein DE, Liedke M, Kaunzner UW, Nealon NM, Gauthier SA, Vartanian T, Perumal JS. 2018. Induction of disease remission with one cycle of alemtuzumab in relapsing-remitting MS.. J Neurol. 265(5):1226-1229.

Pandya S, Kaunzner UW, Rúa SMHurtado, Nealon N, Perumal J, Vartanian T, Nguyen TD, Gauthier SA. 2020. Impact of Lesion Location on Longitudinal Myelin Water Fraction Change in Chronic Multiple Sclerosis Lesions.. J Neuroimaging. 30(4):537-543.

Ma Y, Sannino D, Linden JR, Haigh S, Zhao B, Grigg JB, Zumbo P, Dündar F, Butler DJ, Profaci CP et al.. 2023. Epsilon toxin-producing Clostridium perfringens colonize the MS gut and epsilon toxin overcomes immune privilege.. J Clin Invest.

Parikh NS, Khazanova D, Moya A, Kaunzner UW, Allen BB, Navi BB. 2016. Clinical Reasoning: An unusual case of blurry vision in a young woman after ovarian induction.. Neurology. 87(5):e49-53.

Telesford KM, Kaunzner UW, Perumal J, Gauthier SA, Wu X, Díaz I, Kruse-Hoyer M, Engel C, Marcille M, Vartanian T. 2020. Black African and Latino/a identity correlates with increased plasmablasts in MS.. Neurol Neuroimmunol Neuroinflamm. 7(1)